Boston Area Anticoagulation Trial for Atrial Fibrillation (BAATAF)
Status:
Completed
Trial end date:
1991-06-01
Target enrollment:
Participant gender:
Summary
To determine the benefits and risks of oral anticoagulant therapy in reducing embolic stroke
and systemic emboli in patients with atrial fibrillation without rheumatic heart disease.